aod9604 clinical trial results weight loss efficacy humans Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio AOD-9604 Peptide | USA Made

Some users report subtle increases in energy levels, reduced appetite, or slight improvements in how clothing fits during this initial phase

NNMT inhibition as a therapeutic strategy has been explored in industry pharmaceutical pipelines (including a Pfizer program for non-alcoholic fatty liver disease that was reportedly discontinued in early clinical development), but no NNMT inhibitor has reached regulatory approval to date

Further research is needed to elucidate the mechanisms by which NNMT operates in MetS and to develop therapeutic strategies targeting NNMT

This lab-made peptide is thought to tell your muscles to behave like theyre exercising, even when youre not